A double blind randomized placebo controlled trial of alendronate in primary hyperparathyroidism. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Khan, Aliya
  • Bilezikian, JP
  • Kung, AWC
  • Ahmed, MM
  • Dubois, SJ
  • Ho, AYY
  • Shaikh, A
  • Rubin, M
  • Silverberg, SJ
  • Standish, TI
  • Syed, ZA

publication date

  • September 1, 2003